Share

Data Presented at ENDO 2021 Shows Promise for Treating Cushing’s Syndrome

A poster presented at ENDO 2021 appears to show promise for a new treatment aimed at patients with Cushing’s syndrome. The poster, presented by Strongbridge Biopharma, plc, a global commercial-stage biopharmaceutical company, announced that detailed results from the previously reported Phase 3 LOGICS study of RECORLEV® (levoketoconazole) in patients with endogenous Cushing’s syndrome were presented...
Share

Plenary Pioneers, Part 2: On the Right Track: How the Many Paths of GPCRs Could Lead to Treatment Breakthroughs

Twitter_Post_ENDO_2021_Virtual At ENDO 2021, the first time the Endocrine Society’s annual conference has gone all-virtual, a live Presidential Plenary on March 20 will feature a pair of presentations on the latest developments in basic tissue engineering. Nobel Prize winner Brian Kobilka, MD, talks to Endocrine News about his session, “Structural Insights into G Protein-Coupled Receptor Activation:...
Share

ENDO 2021 Preview: New Studies Tout Potential CAH Therapies

One of the most exciting components of the Endocrine Society’s annual conference is the shear amount of cutting-edge research presented by endocrinology researchers from around the world. ENDO 2021, the very first all-virtual annual conference, is certainly no different in that regard. Studies that could possibly lead to new therapies for a variety of endocrine...
Share

Plenary Pioneers, Part I: When Engineering and Endocrinology Meet

ENDO_2021_4C At ENDO 2021, the first time the Endocrine Society’s annual conference has gone all-virtual, a live Presidential Plenary on March 20 will feature a pair of presentations on the latest developments in basic tissue engineering. Endocrine News speaks with Andrés J. Garcia, PhD, about his session, “Synthetic Hydrogels as Engineered Niches in Regenerative Medicine.”  ...
Share

Fair Trials: The Need for Representation in Clinical Trials

JRG_2018-photo One of the biggest obstacles to medical research is the lack of a truly representative population in clinical trials. For his ENDO Online 2020 session, “Minority Participation in Research: Considerations of Urgency and Strategy,” James R. Gavin III, MD, PhD, will discuss needed steps researchers can take to ensure clinical trials are representative of all...
Show More